^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    allogeneic Myeloma GM-CSF Vaccine

    i
    Associations
    News

    Trials

    Company:
    Sidney Kimmel Comprehensive Cancer Center
    Drug class:
    Immunostimulant, GM-CSF agonist
    Related drugs:
    Associations
    News

    Trials

    Apply
    Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission (NCT01349569)
    Phase 2
    Sidney Kimmel Comprehensive Cancer Center at Jo...
    Completed
    Last update posted :
    01/15/2019
    Initiation :
    01/01/2012
    Primary completion :
    10/01/2016
    Completion :
    10/01/2016
    IFNG
    |
    lenalidomide • allogeneic Myeloma GM-CSF Vaccine